About the Drug Development Session
Drug Development represents the intricate process of bringing new medications from concept to market, involving rigorous research, preclinical testing, clinical trials, and regulatory approvals. This multifaceted journey encompasses the collaboration of researchers, pharmaceutical companies, and regulatory agencies to ensure the safety and efficacy of new drugs. Advances in drug development include targeted therapies, biopharmaceuticals, and precision medicine, aiming to tailor treatments to individual patient profiles. The field continually adapts to technological innovations, such as high-throughput screening and bioinformatics, expediting the discovery of novel therapeutic agents. As a cornerstone of medical progress, drug development plays a pivotal role in addressing unmet medical needs and improving patient outcomes. Key terms associated with Drug Development include preclinical trials, clinical phases, pharmacology, regulatory approvals, and pharmaceutical research. Drug development often involves collaboration among researchers, pharmaceutical companies, academic institutions, and regulatory agencies on a global scale. International cooperation accelerates the exchange of knowledge and resources, contributing to more efficient drug development.
Topics Covered in Drug Development
Preclinical Testing Methods
Clinical Trial Phases
Regulatory Approval Pathways
Targeted Therapy Design
Pharmacokinetics And Pharmacodynamics
Featured Speakers — Drug Development 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Drug Development Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at Nursing 2027
Why Attend the Drug Development Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Drug Development work, reviewed by the scientific committee.
Network Globally
Meet nurse researchers, educators, and clinical leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Drug Development research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join Nursing 2027 for the Drug Development track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Drug Development Conference 2027 — FAQs
What is the Drug Development track at Nursing 2027?
The Drug Development track is a dedicated stream within Nursing 2027 covering the latest research, clinical innovation, and best practice in Drug Development. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Drug Development sessions?
Nurse researchers, advanced practice nurses, educators, doctoral students, and clinical leaders with an interest in Drug Development are all welcome — whether presenting or attending.
Can I present my research in the Drug Development track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Drug Development sessions?
Yes. Nursing 2027 is a hybrid conference — attend the Drug Development track in person in Singapore or join live online, with on-demand access afterward.
Join the Nursing 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.